What We're Reading: Page 318
Industry reads hand-picked by our editors
Dec 23, 2016
-
The Washington Post
Drug industry hired dozens of officials from the DEA as the agency tried to curb opioid abuse
-
The Wall Street Journal
Donald Trump's pick for Health Secretary traded medical stocks while in House
-
Nature
Fatal French clinical trial failed to check data before raising drug dose
-
Bloomberg
Martin Shkreli says ‘of course’ he’d raise drug price again
Dec 22, 2016
Dec 21, 2016
-
The New York Times
Senate aims to stop firms from ‘buying up drugs and jacking up prices’
-
Reuters
Sanofi's takeover talks with Actelion progressing: source
-
The News & Observer
Triangle biotech businesses big winners under new medical research law
-
BloombergGadfly
Biogen's a tough gig for any CEO
Dec 20, 2016
-
The New York Times
Harnessing the U.S. taxpayer to fight cancer and make profits
-
Los Angeles Times
Soaring insulin prices highlight futility of 'free market' for meds
-
Fortune
Here's why investors weren't excited about Biogen's new CEO
-
The Hill
Drugmakers await FDA guidance on 'off-label' uses of medicines
Dec 19, 2016
-
Los Angeles Times
OxyContin goes global - 'We're only just getting started'
-
Reuters
AstraZeneca oncology head jumps ship to become Innate CEO
-
The Wall Street Journal
Hospitals alter routines to control drug spending
-
Bloomberg
Gilead's patent loss to Merck started with a broken friendship
Dec 16, 2016
-
Bloomberg
Stem cells may be the next frontier for diabetes drugmaker Novo
-
The Economist
A new type of molecular medicine may be needed to halt cancers
-
Reuters
India's Aurobindo shares hit nine-month low on US price-fixing lawsuit
-
Life Sci VC
Positive impact of external sourcing on pharma R&D productivity
Dec 15, 2016
-
The Boston Globe
A new moniker and more cash for Flagship Ventures
-
CNBC
Pfizer gets letter from US senators seek information on drug to treat opioid overdoses
-
MIT Technology Review
Google’s long, strange life span trip
-
San Francisco Business Times
Meet Genentech's new CEO as Ian Clark exits for retirement
Previous
